The data have not yet been peer reviewed or published. But experts said the drug may give people with obesity an alternative to bariatric surgery.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2022-04-28 21:43:532022-04-28 21:43:53Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.